Superior renal allograft survival and decreased rejection with early high-dose and sequential multi-species antilymphocyte globulin therapy.
D000818:Animals; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000627:therapeutic use*; D002102:Cadaver; D006084:Graft Rejection; D006085:Graft Survival; D006736:Horses; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D007958:Leukocyte Count; D011817:Rabbits; D013601:T-Lymphocytes / Q000276:immunology; D014181:Transplantation Immunology
D000961:Antilymphocyte Serum